Maximilien Desvages

Lille, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Thrombin generation test as a useful tool for improving disease severity stratification in antiphospholipid syndrome.

Thrombin generation test as a useful tool for improving disease severity stratification in antiphospholipid syndrome.

Journal: RMD open

Published: January 24, 2025

Type 2N von Willebrand disease: genotype drives different bleeding phenotypes and treatment needs.

Type 2N von Willebrand disease: genotype drives different bleeding phenotypes and treatment needs.

Journal: Journal of thrombosis and haemostasis : JTH

Published: January 04, 2024

A small-molecule hemostatic agent for the reversal of direct oral anticoagulant-induced bleeding.

A small-molecule hemostatic agent for the reversal of direct oral anticoagulant-induced bleeding.

Journal: Research and practice in thrombosis and haemostasis

Published: December 22, 2023

Shear Forces Induced Platelet Clearance Is a New Mechanism of Thrombocytopenia.

Shear Forces Induced Platelet Clearance Is a New Mechanism of Thrombocytopenia.

Journal: Circulation research

Published: October 26, 2023

Emicizumab does not interfere with the activated clotting time.

Emicizumab does not interfere with the activated clotting time.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: September 01, 2021

Endothelial Dysfunction as a Component of Severe Acute Respiratory Syndrome Coronavirus 2-Related Multisystem Inflammatory Syndrome in Children With Shock.

Endothelial Dysfunction as a Component of Severe Acute Respiratory Syndrome Coronavirus 2-Related Multisystem Inflammatory Syndrome in Children With Shock.

Journal: Critical care medicine

Published: May 28, 2021

Reappearance of inhibitor in a tolerized patient with severe haemophilia A during FVIII-free emicizumab therapy.

Reappearance of inhibitor in a tolerized patient with severe haemophilia A during FVIII-free emicizumab therapy.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: February 16, 2021

Non-inhibitory antibodies inducing increased emicizumab clearance in a severe haemophilia A inhibitor patient.

Non-inhibitory antibodies inducing increased emicizumab clearance in a severe haemophilia A inhibitor patient.

Journal: Haematologica

Published: February 15, 2021

Showing 1-8 of 8

Last Updated: 09/26/2026